Trademark: 97196369
Word
SUPERDONOR
Status
Registered
Status Code
700
Status Date
Tuesday, September 5, 2023
Serial Number
97196369
Registration Number
7153599
Registration Date
Tuesday, September 5, 2023
Mark Type
3000
Filing Date
Thursday, December 30, 2021
Published for Opposition
Tuesday, June 20, 2023

Trademark Owner History
MYBIOTICS PHARMA LTD - Original Registrant

Classifications
5 Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks; dietary food supplements; dietary supplement drink mixes in the nature of vitamin and mineral beverages; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; non-prescription medicines, namely, medicinal preparations in the nature of pills, tablets, capsules, caplets, liquid drops, sachets, oral liquids, suspensions, liquids, semi-solids, creams, syrups, ointments, lotions, gels, sprays, emulations, oils, pessaries, suppositories, granules and films for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of bacterial vaginosis and vaginal related women health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; medicines for dental purposes; medicines for veterinary purposes namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations and substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; pain relief medication; decongestant capsules; herbal medicines, namely, medicinal herbal preparations, herbal pharmaceutical preparations and herbal substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; antihypertensives; antitussives; diarrhea medication; antiflatulants ; antiemetics; antivirals; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; medicines for treating gastrointestinal diseases
The mark consists of the wording "SUPERDONOR" in stylized font, with a dot to the left side of the initial "S" and also in the center of the second "O" of DONOR; the first "O" of DONOR is in a shape of a lens of a magnifying glass.
SUPER DONOR
"SUPER DONOR"

Trademark Events
Sep 5, 2023
Notice Of Registration Confirmation Emailed
Sep 5, 2023
Registered-Principal Register
Jun 20, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2023
Published For Opposition
May 31, 2023
Notification Of Notice Of Publication E-Mailed
May 15, 2023
Electronic Record Review Complete
May 12, 2023
On Hold - Electronic Record Review Required
May 9, 2023
Approved For Pub - Principal Register
Apr 10, 2023
Teas/Email Correspondence Entered
Apr 9, 2023
Correspondence Received In Law Office
Apr 9, 2023
Teas Response To Office Action Received
Feb 21, 2023
Assigned To Examiner
Oct 11, 2022
Notification Of Non-Final Action E-Mailed
Oct 11, 2022
Non-Final Action E-Mailed
Oct 11, 2022
Non-Final Action Written
Oct 5, 2022
Assigned To Examiner
Jan 6, 2022
Notice Of Design Search Code E-Mailed
Jan 5, 2022
New Application Office Supplied Data Entered
Jan 3, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24